Department of Internal Medicine, Cardiovascular Genetics Division, University of Utah, Salt Lake City, Utah, USA.
Obesity (Silver Spring). 2010 Jan;18(1):121-30. doi: 10.1038/oby.2009.178. Epub 2009 Jun 4.
Favorable health outcomes at 2 years postbariatric surgery have been reported. With exception of the Swedish Obesity Subjects (SOS) study, these studies have been surgical case series, comparison of surgery types, or surgery patients compared to subjects enrolled in planned nonsurgical intervention. This study measured gastric bypass effectiveness when compared to two separate severely obese groups not participating in designed weight-loss intervention. Three groups of severely obese subjects (N = 1,156, BMI >or= 35 kg/m(2)) were studied: gastric bypass subjects (n = 420), subjects seeking gastric bypass but did not have surgery (n = 415), and population-based subjects not seeking surgery (n = 321). Participants were studied at baseline and 2 years. Quantitative outcome measures as well as prevalence, incidence, and resolution rates of categorical health outcome variables were determined. All quantitative variables (BMI, blood pressure, lipids, diabetes-related variables, resting metabolic rate (RMR), sleep apnea, and health-related quality of life) improved significantly in the gastric bypass group compared with each comparative group (all P < 0.0001, except for diastolic blood pressure and the short form (SF-36) health survey mental component score at P < 0.01). Diabetes, dyslipidemia, and hypertension resolved much more frequently in the gastric bypass group than in the comparative groups (all P < 0.001). In the surgical group, beneficial changes of almost all quantitative variables correlated significantly with the decrease in BMI. We conclude that Roux-en-Y gastric bypass surgery when compared to severely obese groups not enrolled in planned weight-loss intervention was highly effective for weight loss, improved health-related quality of life, and resolution of major obesity-associated complications measured at 2 years.
术后 2 年报告了有利的健康结果。除了瑞典肥胖受试者(SOS)研究外,这些研究都是手术病例系列、手术类型比较或手术患者与计划进行非手术干预的受试者比较。本研究比较了胃旁路手术与两组未参与设计减重干预的重度肥胖患者的效果。研究了三组严重肥胖受试者(N=1156,BMI≥35kg/m2):胃旁路手术组(n=420)、寻求胃旁路手术但未接受手术的受试者(n=415)和未寻求手术的基于人群的受试者(n=321)。参与者在基线和 2 年时进行了研究。确定了定量结果测量以及分类健康结果变量的患病率、发病率和解决率。胃旁路组的所有定量变量(BMI、血压、血脂、糖尿病相关变量、静息代谢率(RMR)、睡眠呼吸暂停和健康相关生活质量)均显著改善,与每个对照组相比(均 P<0.0001,除舒张压和短格式(SF-36)健康调查心理成分评分外 P<0.01)。与对照组相比,胃旁路组糖尿病、血脂异常和高血压的发生率更高(均 P<0.001)。在手术组中,几乎所有定量变量的有益变化与 BMI 的减少显著相关。我们得出结论,与未参与计划减重干预的重度肥胖组相比,Roux-en-Y 胃旁路手术对体重减轻、改善健康相关生活质量和解决主要肥胖相关并发症非常有效,这些效果在 2 年时得到了测量。